NBIX · Neurocrine Biosciences Inc · Fails to Deliver
$143.00
-3.38 (-2.31%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$14.88B
Shares
101.65M
Volume · Oct 30
1.32M
Avg daily vol (3M)
1.3M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-11 | 1,221 | $156.57 | $191,172 |
| 2026-09-09 | 11 | $155.13 | $1,706 |
| 2026-09-08 | 19 | $155.64 | $2,957 |
| 2026-08-28 | 1,609 | $155.92 | $250,875 |
| 2026-08-12 | 20 | $161.94 | $3,239 |
| 2026-08-07 | 1 | $159.82 | $160 |
| 2026-08-03 | 5,960 | $166.80 | $994,128 |
Showing 1–7 of 7 settlements
Key facts
CIK
914475
CUSIP
64125C109
13F (30d)
240 filings
224 filers
Visit website
Investor relations